Real-World Analyses of the Treatment Conditions in Patients Initiating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor in Taiwan
Article in Journal of Atherosclerosis and Thrombosis (November 2022)
The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.
Article in Journal of Atherosclerosis and Thrombosis (November 2022)
Article in Journal of the American Heart Association (July 2022)
Article in Physiological Research (August 2021)